- BioRN Network
- Cluster Management
About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
December 06, 2013
DKFZ: Cancer survival rates in Europe continue to increase
December 05, 2013
Apogenix’ APG350 Effectively Induces Apoptosis of Tumor Cells via TRAIL Pathway Independent of Fcγ Cross-Linking
December 02, 2013
Merck Serono’s new spin - off TocopheRx to focus on infertility treatment
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here